Prognostic factors in pediatric Hodgkin disease
The sensitivity of pediatric Hodgkin disease to radiation and chemotherapy has resulted in cure for most children and adolescents who have been diagnosed in the past three decades. Identification of prognostic factors in clinical trials has allowed for tailoring of therapeutic approaches to improve outcome in sequential trials. Tumor burden, symptoms, clinical features, pathology, response to therapy, biology, and host factors are reviewed in this context. New developments should be directed toward identification of factors associated with biologic mechanisms of disease to facilitate the development of biologically targeted therapies that will be more efficacious and less toxic.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Schwartz CL, Tebbi C, Constine LS, et al.: Response-based therapy for pediatric Hodgkin’s disease: Pediatric Oncology Group (POG) Protocols 9425/9426 [abstract]. Med Pediatr Oncol 2001, 37:263.Google Scholar
- 3.Landman-Parker J, Pacquement H, Leblanc T, et al.: Localized childhood Hodgkin’s disease: response adopted chemotherapy with etoposide, bleomycin, vinblastin, and prednisone before low-dose raditaion therapy: results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 2000, 18:1500–1507. This study provides an important proposal for a prognostic system for children and offers a view of the use of response-directed therapy.PubMedGoogle Scholar
- 5.Nachman JB, Sposto R, Herzog P, et al.: Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin’s disease who achieve a complete response to chemotherapy. J Clin Oncol 2002, 20:3765–3771. Report from a large randomized trial in pediatric Hodgkin disease assessing the possibility of reducing therapy (eliminating radiation) in those in complete response at the end of therapy. Relapse rates were higher in those who were not irradiated, suggesting that complete response at the end of therapy may not be a sufficiently good prognostic indicator to limit radiotherapy.PubMedCrossRefGoogle Scholar
- 18.Von Wasielewski R, Seth S, Franklin J, et al.: Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors. Blood 2000, 95:1207–1213.Google Scholar
- 23.Von Wasielewski R, Mengel M, Fischer R, et al.: Classical Hodgkin’s disease: clinical impact of the immunophenotype. Am J Pathol 1997, 151:1123–1130.Google Scholar
- 26.Weiner MA, Leventhal B, Brecher ML, et al.: Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin’s disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 1997, 15:1769–1779.Google Scholar
- 28.Dieckmann K, Potter R, Hofmann J, et al.: Does bulky disease at diagnosis influence outcome in childhood Hodgkin’s disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. Int Radiat Oncol Biol Phys 2003, 56:644–652. This is a critically important analysis of the important prognostic factors in pediatric Hodgkin disease. It shows that NSII histology and “B” symptoms, both related to the biology of Hodgkin disease, are more significant prognostic factors than traditional measures of disease burden.CrossRefGoogle Scholar
- 35.Wickmann L, Luders H, Dorffel W: 18-FDG-PET-findings in children and adolescents with Hodgkin’s disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations [in German]. Klin Padiatr 2003, 215:146–150. An important study for consideration as we begin to use PET scans for staging and prediction of response in pediatric Hodgkin disease.PubMedCrossRefGoogle Scholar
- 45.Samy SM, Richter BWM, Duckett CS: Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin’s disease cells. Blood 2000, 96:4307–4312.Google Scholar